SMA 50 společnosti Novabay Pharmaceuticals Inc
Jaká je hodnota metriky SMA 50 společnosti Novabay Pharmaceuticals Inc?
Hodnota metriky SMA 50 společnosti Novabay Pharmaceuticals Inc je $1 -68.74%
Jaká je definice metriky SMA 50?
SMA 50 je průměrná cena akcií z posledních 50 dnů vypočítaná jako nevážený průměr předchozích 50 závěrečných cen.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 společností v sektoru Health Care sektor na NYSEMKT ve srovnání se společností Novabay Pharmaceuticals Inc
Čemu se věnuje společnost Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Firmy s metrikou sma 50 podobnou společnosti Novabay Pharmaceuticals Inc
- Hodnota metriky SMA 50 společnosti Teuton Resources je $1 +18.84%
- Hodnota metriky SMA 50 společnosti Spark Power je CAD$1 +1.88%
- Hodnota metriky SMA 50 společnosti AirNet Technology je $1 -136.76%
- Hodnota metriky SMA 50 společnosti Arts Optical International je $1 -0.94%
- Hodnota metriky SMA 50 společnosti Future Enterprises je ₨1 +13.10%
- Hodnota metriky SMA 50 společnosti Solitario Resources Corp je $1 -13.64%
- Hodnota metriky SMA 50 společnosti Novabay Pharmaceuticals Inc je $1 -68.74%
- Hodnota metriky SMA 50 společnosti ImmunoPrecise Antibodies je $1 -27.46%
- Hodnota metriky SMA 50 společnosti EVRAZ Plc je GBX1 +99.00%
- Hodnota metriky SMA 50 společnosti Galeo Concept SA je €1 +53.71%
- Hodnota metriky SMA 50 společnosti ESG Capital 1 je CAD$1 -35.00%
- Hodnota metriky SMA 50 společnosti Acorn Capital Investment Fund je AUD$1 -0.76%
- Hodnota metriky SMA 50 společnosti China Molybdenum Co je $1 -17.57%